In silico studies on therapeutic agents for COVID-19: Drug repurposing approach
Aims The severe acute respiratory syndrome coronavirus 2, better known as COVID-19 has
become the current health concern to the entire world. Initially appeared in Wuhan, China …
become the current health concern to the entire world. Initially appeared in Wuhan, China …
Drug repurposing strategy (DRS): Emerging approach to identify potential therapeutics for treatment of novel coronavirus infection
BM Sahoo, BVV Ravi Kumar, J Sruti… - Frontiers in Molecular …, 2021 - frontiersin.org
Drug repurposing is also termed as drug repositioning or therapeutic switching. This method
is applied to identify the novel therapeutic agents from the existing FDA approved clinically …
is applied to identify the novel therapeutic agents from the existing FDA approved clinically …
[PDF][PDF] The molecular docking study of potential drug candidates showing anti-COVID-19 activity by exploring of therapeutic targets of SARS-CoV-2
RR Narkhede, RS Cheke, JP Ambhore… - Eurasian J. Med …, 2020 - academia.edu
Objectives: The novel human coronavirus designated severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) first emerged in late 2019 in Wuhan, China. This virus spread …
coronavirus 2 (SARS-CoV-2) first emerged in late 2019 in Wuhan, China. This virus spread …
In-silico drug repurposing for targeting SARS-CoV-2 main protease (Mpro)
COVID-19, caused by novel coronavirus or SARS-CoV-2, is a viral disease which has
infected millions worldwide. Considering the urgent need of the drug for fighting against this …
infected millions worldwide. Considering the urgent need of the drug for fighting against this …
In silico molecular docking analysis for repurposing therapeutics against multiple proteins from SARS-CoV-2
RR Deshpande, AP Tiwari, N Nyayanit… - European journal of …, 2020 - Elsevier
SARS-CoV-2 has devastated the world with its rapid spread and fatality. The researchers
across the globe are struggling hard to search a drug to treat this infection. Understanding …
across the globe are struggling hard to search a drug to treat this infection. Understanding …
In silico analysis of selected alkaloids against main protease (Mpro) of SARS-CoV-2
In the present situation, COVID-19 has become the global health concern due to its high
contagious nature. It initially appeared in December 2019 in Wuhan, China and now …
contagious nature. It initially appeared in December 2019 in Wuhan, China and now …
[HTML][HTML] Identification of multipotent drugs for COVID-19 therapeutics with the evaluation of their SARS-CoV2 inhibitory activity
The SARS-CoV2 is a highly contagious pathogen that causes COVID-19 disease. It has
affected millions of people globally with an average lethality of~ 3%. There is an urgent need …
affected millions of people globally with an average lethality of~ 3%. There is an urgent need …
[HTML][HTML] In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2
Background The unique anthropological coronavirus which has been titled as SARS-CoV-2
was originally arisen in late 2019 in Wuhan, China affecting respiratory infection named as …
was originally arisen in late 2019 in Wuhan, China affecting respiratory infection named as …
In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors
MAA Ibrahim, AHM Abdelrahman… - Journal of biomolecular …, 2021 - Taylor & Francis
Herein, the DrugBank database which contains 10,036 approved and investigational drugs
was explored deeply for potential drugs that target SARS-CoV-2 main protease (Mpro) …
was explored deeply for potential drugs that target SARS-CoV-2 main protease (Mpro) …
In silico virtual screening, characterization, docking and molecular dynamics studies of crucial SARS-CoV-2 proteins
M Alazmi, O Motwalli - Journal of Biomolecular Structure and …, 2021 - Taylor & Francis
The ongoing pandemic COVID-19 (COrona Virus Immuno Deficiency-2019) which is caused
by SARS-CoV-2 (Severe Acute Respiratory Syndrome–CoronaVirus-2) has emerged as a …
by SARS-CoV-2 (Severe Acute Respiratory Syndrome–CoronaVirus-2) has emerged as a …